DSA VASCULAR FEATURES ASSOCIATED WITH SEVERE HEMOPTYSIS AND EARLY HEMOSTATIC OUTCOMES AFTER ARTERIAL EMBOLIZATION

Văn Sang Nguyễn1, , Quốc Vũ Đặng2, Phan Ninh Trần3, Việt Hà Phạm2,3, Trường Giang Nguyễn2,3
1 Bệnh viện E
2 Bệnh viện Trung ương Thái Nguyên
3 Trường Đại học Y - Dược, Đại học Thái Nguyên

Main Article Content

Abstract

Objective: To assess the association between selected vascular features on digital subtraction angiography (DSA) and severe hemoptysis, and to describe early hemostatic outcomes after bronchial and/or non-bronchial systemic artery embolization.


Materials and Methods: A descriptive cross - sectional study, combined retrospective and prospective data collection in 34 patients with hemoptysis who underwent arterial embolization at Thai Nguyen National Hospital from January 2024 to June 2026. DSA vascular features, hemoptysis severity, and early post-embolization outcomes were recorded. Data were analyzed using SPSS 25.0.


Results: Severe hemoptysis occurred in 52.9% (18/34). The largest bronchial artery diameter on DSA was 2.73 ± 0.49 mm in the mild group, 2.94 ± 0.52 mm in the moderate group, and 3.72 ± 1.01 mm in the severe group. Plexiform/reticular vascular proliferation was present in 88.9% of severe and 37.5% of non-severe cases (OR = 13.33; 95% CI: 2.24 - 79.44; p = 0.003); aneurysm was observed in 38.9% of severe cases and in none of the non-severe cases (95% CI: 1.12 - 415.37; p = 0.008); and arteriovenous shunt was present in 38.9% versus 6.2% (OR = 9.55; 95% CI: 1.02 - 89.23; p = 0.043). Non-bronchial systemic arteries were not significantly associated with severe hemoptysis (OR = 3.00; 95% CI: 0.70 - 12.93; p = 0.172). Technical success was 100.0% and early clinical success was 97.1%. No in-hospital visceral infarction was recorded.


Conclusion: Plexiform/reticular vascular proliferation, aneurysm, and arteriovenous shunt on DSA were associated with severe hemoptysis in this embolized cohort. Arterial embolization achieved high technical and early clinical success rates.

Article Details

References

1. Đào Ngọc Bằng, Bạch Quốc Tuấn, Tạ Bá Thắng. Kết quả gây tắc động mạch phế quản điều trị ho ra máu tại Trung tâm Hô hấp, Bệnh viện Quân y 103 trong 5 năm. Tạp chí Y học Việt Nam. 2023;525(1A). doi:10.51298/vmj.v525i1A.4932.
2. Nguyễn Trường Giang, Lê Anh Quang, Nguyễn Thị Hà. Điều trị ho ra máu cấp tính bằng nút động mạch phế quản và ngoài phế quản sử dụng phối hợp hai loại vật liệu nút mạch. Điện quang Việt Nam. 2015;(22):49–53.
3. Almeida J, Leal C, Figueiredo L. Evaluation of the bronchial arteries: normal findings, hypertrophy and embolization in patients with hemoptysis. Insights Imaging. 2020;11:70. doi:10.1186/s13244-020-00877-4.
4. Dohna M, Kühl H, Sutharsan S, Dohna-Schwake C, Vo Chieu VD, Hellms S, et al. Bronchial artery diameter in massive hemoptysis in cystic fibrosis. BMC Pulm Med. 2022;22:424. doi:10.1186/s12890-022-02233-2.
5. Kettenbach J, Ittrich H, Gaubert JY, Gebauer B, Vos JA. CIRSE Standards of Practice on Bronchial Artery Embolisation. Cardiovasc Intervent Radiol. 2022;45(6):721–732. doi:10.1007/s00270-022-03127-w.
6. Mazıcan M, Karluka I, Fındıkcıoğlu A, Andıc C. Bronchial artery embolization in patients with life-threatening massive hemoptysis: comparison of the efficacy and safety of particulate embolizing agents and n-2-butyl-cyanoacrylate. Eur Rev Med Pharmacol Sci. 2024;28(1):310–318. doi:10.26355/eurrev_202401_34918.
7. Quigley N, Gagnon S, Fortin M. Aetiology, diagnosis and treatment of moderate-to-severe haemoptysis in a North American academic centre. ERJ Open Res. 2020;6(4):00204-2020. doi:10.1183/23120541.00204-2020.
8. Tao Y, Li J, Su R. The efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis. Cardiovasc Diagn Ther. 2024;14(5):859–877. doi:10.21037/cdt-24-157.